Modern WisdomHow Do Psychedelics Treat PTSD? - Dr Martin Polanco & Michael Higgs
CHAPTERS
- 0:00 – 1:33
Meeting through The Mission Within & why psychedelics felt scary
Michael and Dr. Martin Polanco explain how they first connected through The Mission Within, a psychedelic treatment program for special operations veterans. Michael sets the tone: the fear wasn’t combat, it was what the medicine might reveal about themselves.
- •The Mission Within’s role treating veterans since 2015
- •Michael’s first exposure via friends who had been treated
- •Fear of confronting the self vs fear of overseas operations
- •Early framing of psychedelics as “medicine,” not recreation
- 1:33 – 2:31
When ‘the train of life’ catches up: layered trauma, loss, and injury
Michael details how decades of childhood trauma, family instability, combat losses, moral injury, and repeated blast exposure accumulated. He describes relying on pain meds and psychotropics to keep functioning until a breaking point.
- •Childhood trauma and major relationship stressors (divorces, opioid addiction in family)
- •Loss of friends and moral injury from war
- •Blast exposure from training/combat and cognitive decline
- •Medication as masking: pain pills and psychotropics to keep going
- 2:31 – 6:24
Pain management, brain symptoms, and the ‘smile at work’ culture
Chris and Michael explore the added stakes of elite military roles when you’re struggling physically and mentally. Michael explains how spec ops culture discourages going to medical, and how fear of being sidelined drives under-reporting of issues.
- •Breacher/sniper roles and the pressure to perform despite decline
- •Migraines, memory loss, and frustration compounding distress
- •Incentive conflict: seeking help vs staying operational
- •Fear of disclosure: “how much do I share before I’m grounded?”
- 6:24 – 10:08
Why elite teams feel close—but people still hide the underbelly
Michael argues that even in tight-knit units, people often don’t truly know each other because vulnerability is risky. They discuss whether openness can be institutionalized early without undermining perceived strength and effectiveness.
- •“We don’t know shit about each other” behind the team veil
- •Deep personal pain is rarely shared in-unit
- •Fear of being seen as weak or holding others back
- •Possibility of building trust/vulnerability earlier in the pipeline
- 10:08 – 11:26
The tipping point: reputation, leadership pressure, and suicidality
Michael describes how he held high status and responsibility while quietly struggling, and how pride kept him from seeking help. After retirement, additional losses and a friend’s breakdown triggered his own crisis and suicidal state, prompting outreach.
- •High-level enlisted leadership and reputation management
- •Pride as a double-edged sword in small, selective units
- •Post-retirement stressors and compounding losses
- •Suicidal crisis as the moment he sought help
- 11:26 – 13:27
Dr. Polanco’s origin story: ibogaine, addiction, and trauma underneath
Martin recounts how helping a family member with cocaine addiction led him to ibogaine and changed his medical path. He emphasizes addiction as self-medication for deeper pain—often trauma—rather than moral failure.
- •Discovering ibogaine in 1999 via documentary and early providers
- •Witnessing rapid perspective shift after treatment
- •Leaving ophthalmology track to start an ibogaine clinic in Mexico (2000)
- •Addiction framed as coping/self-medication rooted in trauma
- 13:27 – 18:26
From addiction to PTSD: veterans, COVID, and brain injury as the core issue
Martin explains how veterans reported PTSD relief and why that was clinically striking. He connects the surge in need during COVID to isolation and loss of outlets, and stresses mild traumatic brain injury from overpressure as a foundational driver of symptoms.
- •2015: veterans treated for heroin report PTSD resolution
- •COVID factors: gym closures, isolation, increased awareness of options
- •mTBI from blasts/overpressure (not only IEDs)
- •Inflammation and hormone dysregulation leading to anger, insomnia, depression
- 18:26 – 21:33
The ‘operator syndrome’ profile: symptoms, meds, sleep, and interrelated failures
They outline a common presentation: high-performing men with complex overlapping issues—TBI, PTSD, pain, insomnia, mood disruption, and family stress. Both highlight polypharmacy and the difficulty of tapering medications while rebuilding sleep and health.
- •Demographics: many post-9/11, Type A, elite performers
- •Operator syndrome: hormones, insomnia, anger, depression/anxiety, pain, sleep apnea
- •Sleep disruption as a compounding injury; diet and alcohol worsening inflammation
- •Polypharmacy (12–13 meds) and the tapering rebound problem
- 21:33 – 25:30
Entering the retreat: screening, coaching, intentions, and ‘first-time’ fear
Michael walks through the treatment container: medical screening, preparation coaching, peer support, trauma therapy, and ceremony. The emphasis is on set/setting and intention—building safety for people terrified of what they might uncover.
- •Medical screening: labs, heart checks, contraindications and tapering meds
- •Preparation coaching: intentions, expectation setting, navigation skills
- •Peer-based support: veteran coaches and trauma therapist on-site
- •Fire ceremony and written intentions before dosing
- 25:30 – 29:17
Ibogaine journey: reliving life with distance, reconciliation, and mental quiet
Michael describes ibogaine as a structured life review—connecting people/events like a targeting link diagram—allowing him to revisit trauma without being overwhelmed by emotion. He reports reconciliation, forgiveness, and a striking ‘quiet mind’ afterward.
- •The ‘pill in hand’ moment and point-of-no-return commitment
- •Life review mechanics: people/events connected across time and causality
- •Trauma revisited without re-traumatization; perspective and forgiveness
- •10–12 hour duration; taxing on the body; post-journey mental stillness
- 29:17 – 33:34
5-MeO-DMT: emotional release, ego dissolution, and surrender challenges
The next-day 5-MeO session is framed as intense emotional unearthing and energetic discharge leading to ego dissolution and reconnection. Michael shares how he resisted overwhelming love, feared he ‘failed,’ and why integration coaching prevented a destructive interpretation.
- •5-MeO described as deeply emotional vs ibogaine’s cerebral review
- •External appearance may look chaotic; internal process is emotional expulsion
- •Ego dissolution and reconnection as a core therapeutic outcome
- •Importance of coaching to reframe resistance and support ongoing work
- 33:34 – 41:23
How psychedelics may ‘restructure’ PTSD: receptors, neurotrophins, inflammation, and mysticism
Martin explains multi-layer mechanisms: broad receptor activity, increased hemispheric communication, neurogenesis via BDNF/GDNF, and reduced inflammation—especially relevant to mTBI. Psychologically, ibogaine supports ‘shadow work’ and recontextualization; spiritually, 5-MeO can generate unity/oneness that aids integration.
- •Ibogaine impacts ~50 receptors; dopamine/serotonin/opioid systems
- •Neurogenesis markers: BDNF and GDNF; improved brain connectivity
- •Pre-verbal trauma and observer perspective enabling recontextualization
- •5-MeO mystical experience + anti-inflammatory effects; synergy with ibogaine
- 41:23 – 48:12
Access, legality, and choosing modalities: ketamine, MDMA, mushrooms, and constraints
They discuss what’s available legally, why many travel abroad, and why certain medicines are used or avoided. Martin outlines ketamine as a legal, short-term option for acute suicidality, MDMA’s legal barriers in Mexico, and sustainability/lineage issues around peyote and ayahuasca.
- •In the US, ketamine is broadly legal; others mostly limited to trials/expanded access
- •Mexico: ibogaine and 5-MeO legal; psilocybin in a gray ceremonial area
- •MDMA legality constraints; Jamaica plans for more open psilocybin work
- •Avoiding peyote due to sustainability; ayahuasca requires lineage training
- 48:12 – 49:57
Risks, screening, and integration pitfalls: mania, psychosis, and ‘reactivations’
Martin addresses contraindications and why careful screening matters, especially for mania or psychotic disorders. He highlights that challenging after-effects often stem from poor integration—lack of grounding, sleep, and nutrition—rather than the acute experience alone.
- •Contraindications: mania, schizophrenia/voices, poor reality testing, drug interactions
- •Ibogaine cardiac risks and arrhythmia potential in combinations
- •5-MeO integration difficulties and ‘reactivations’/flashbacks
- •Grounding practices (food, shower, massage) and follow-up support reduce spin-outs
- 49:57 – 58:56
Life after treatment: rebuilding habits, community, and giving back
Michael explains recovery as ongoing ‘onion peeling’—medicine moved the boulder, but lifestyle and mindset sustain change. He focuses on controllables (sleep, inputs, thoughts), improved relationships, and transitioning into coaching and operations to help others reach out sooner.
- •Healing as a long process; medicine as catalyst, not a crutch
- •Daily controllables: sleep, diet, attention, thought patterns, mindfulness
- •Community support and increased authenticity in relationships
- •Advice to veterans: reach out; most are referred by others; pathways to Mission Within
